InsidersTradesSigma
Follow the 辰欣药业 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 辰欣药业 has recorded 3 public disclosures. Market capitalisation: €6.3bn. The latest transaction was filed on 20 October 2022 (Purchase). Among the most active insiders: 杜振新. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
辰欣药业是一家在上海证券交易所上市的健康和制药公司。该公司专注于创新药物的研发和制造。